SHL Telemedicine Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
3.46
Earnings per Share (EPS)
N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
114.06-3.97-6.3528.176.4310.37507.85-21.11-3.27K-15.20112.186.43
Price/Sales ratio
2.361.911.731.811.331.413.515.934.211.882.591.33
Price/Book Value ratio
1.541.552.952.321.731.703.725.174.471.452.001.73
Price/Cash Flow ratio
-30.3316.61-164.315.725.115.4430.151.58K-3.41K-71.7322.815.11
Price/Free Cash Flow ratio
-12.7853.77-31.426.625.666.6548.51-95.69-35.67-15.35806.205.66
Price/Earnings Growth ratio
-1.790.000.19-0.230.01-0.23-5.370.0032.91-0.000.060.01
Dividend Yield
N/AN/AN/AN/AN/A17.77%N/AN/AN/AN/AN/A17.77%
Profitability Indicator Ratios
Gross Profit Margin
55.69%40.55%51.96%52.41%61.83%56.01%51.39%49.60%46.08%44.25%54.20%56.01%
Operating Profit Margin
3.21%-44.50%-11.81%10.96%24.53%11.39%0.98%0.10%-8.75%-15.77%5.04%11.39%
Pretax Profit Margin
4.63%-45.60%-17.75%8.06%23.46%11.39%0.19%-27.16%2.22%-10.44%4.65%11.39%
Net Profit Margin
2.07%-48.10%-27.36%6.44%20.75%13.59%0.69%-28.08%-0.12%-12.36%2.30%13.59%
Effective Tax Rate
55.26%-5.47%-54.15%20.10%11.54%-19.34%-261.03%-3.37%83.61%-14.93%50.40%11.54%
Return on Assets
0.89%-22.34%-17.71%3.67%18.26%9.52%0.42%-10.74%-0.06%-6.24%0.81%9.52%
Return On Equity
1.35%-39.05%-46.59%8.24%26.91%16.39%0.73%-24.49%-0.13%-9.59%1.81%16.39%
Return on Capital Employed
1.69%-28.27%-12.97%12.58%30.56%10.04%0.78%0.04%-5.55%-9.41%2.06%10.04%
Liquidity Ratios
Current Ratio
2.451.070.960.841.421.101.23N/AN/AN/A2.381.42
Quick Ratio
2.300.900.870.771.341.011.142.391.592.091.551.34
Cash ratio
0.200.190.220.170.270.490.280.850.250.381.010.27
Days of Sales Outstanding
145.6274.67100.48141.0850.9549.3249.9059.8456.8360.55N/A49.32
Days of Inventory outstanding
51.1658.0244.7445.3125.5022.5025.6561.3744.5139.6898.3525.50
Operating Cycle
196.79132.69145.23186.4076.4571.8375.56121.22101.34100.2498.3576.45
Days of Payables Outstanding
20.2518.0221.2619.6621.0922.2330.4042.1343.1144.5680.1321.09
Cash Conversion Cycle
176.53114.67123.96166.7355.3549.6045.1679.0858.2355.67-55.8749.60
Debt Ratios
Debt Ratio
0.250.260.370.210.01N/A0.030.140.130.110.510.01
Debt Equity Ratio
0.370.460.980.490.02N/A0.060.330.270.171.120.02
Long-term Debt to Capitalization
0.170.180.280.04N/AN/AN/A0.230.180.120.31N/A
Total Debt to Capitalization
0.270.310.490.330.02N/A0.050.250.210.140.340.02
Interest Coverage Ratio
1.24-16.07-0.381.1436.0919.572.33N/AN/AN/A1.5819.57
Cash Flow to Debt Ratio
-0.130.20-0.010.8213.68N/A2.000.00-0.00-0.110.16N/A
Company Equity Multiplier
1.501.742.622.241.471.721.712.271.981.532.191.47
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.070.11-0.010.310.260.250.110.00-0.00-0.020.110.25
Free Cash Flow / Operating Cash Flow Ratio
2.370.305.220.860.900.810.62-16.6195.574.670.020.81
Cash Flow Coverage Ratio
-0.130.20-0.010.8213.68N/A2.000.00-0.00-0.110.16N/A
Short Term Coverage Ratio
-0.300.38-0.030.9113.68N/A2.000.10-0.03-0.691.04N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/A184.42%N/AN/AN/AN/AN/A184.42%